Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2013
10/16/2013CN101535344B Novel antiproliferation antibodies
10/16/2013CN101245101B Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146
10/15/2013US8557967 Anti-interferon-α antibodies
10/15/2013US8557966 Folate receptor 1 antibodies and immunoconjugates and uses thereof
10/15/2013US8557965 Single variable domains against notch pathway members
10/15/2013US8557964 Anti CXCR4 antibodies and their use for the treatment of cancer
10/15/2013US8557961 Alpha 1-antitrypsin compositions and methods of making and using same
10/15/2013US8557780 Monomethylvaline compounds capable of conjugation to ligands
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557546 Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseases
10/15/2013US8557535 Methods for preparation of platelet rich plasma
10/15/2013US8557245 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
10/15/2013US8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
10/15/2013US8557243 EFGR antibodies comprising modular recognition domains
10/15/2013US8557242 ERBB2 antibodies comprising modular recognition domains
10/15/2013US8557241 Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents
10/15/2013US8557240 Method for the treatment of inflammatory disorders
10/15/2013US8557238 EG-VEGF nucleic acids and polypeptides and methods of use
10/15/2013CA2773169C Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
10/15/2013CA2715103C Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods
10/15/2013CA2555699C Monoclonal antibody based biomarker discovery and development platform
10/15/2013CA2548942C Anti-sars monoclonal antibodies
10/15/2013CA2544562C Bispecific antibodies
10/15/2013CA2535510C Detecting and profiling molecular complexes
10/15/2013CA2410762C Feline hepatocyte growth factor
10/15/2013CA2402214C T1r taste receptors and genes encoding same
10/15/2013CA2373721C Compounds that bind her2
10/10/2013WO2013152024A1 Humanized and chimeric anti-factor c3 antibodies and uses thereof
10/10/2013WO2013152020A1 Humanized and chimeric anti-factor bb antibodies and uses thereof
10/10/2013WO2013152011A1 Novel human control antibodies and uses therefor
10/10/2013WO2013152001A2 Anti-hla-b*27 antibodies and uses thereof
10/10/2013WO2013151762A1 Humanized tau antibody
10/10/2013WO2013151662A2 Therapies, vaccines, and predictive methods for infectious salmon anemia virus
10/10/2013WO2013151649A1 Glycan-interacting compounds
10/10/2013WO2013150623A1 Conjugate of anti-cdh3 (p-cadherin) antibody and drug
10/10/2013WO2013150518A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
10/10/2013WO2013150043A1 Bispecific antibodies against human tweak and human il17 and uses thereof
10/10/2013WO2013149526A1 Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and t cell antigen
10/10/2013WO2013149306A1 Antibodies to htra3
10/10/2013WO2013121441A3 Synthetic peptides capable of binding to influenza hemagglutinin protein
10/10/2013WO2013101771A3 Compositions and method for treating autoimmune diseases
10/10/2013WO2013096732A3 Methods of treating or preventing viral diseases by blocking interleukin-21
10/10/2013WO2013090644A3 Anti-hiv antibodies having increased potency and breadth
10/10/2013WO2013066879A3 SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE
10/10/2013US20130267689 Antibodies and diagnostics
10/10/2013US20130267688 Novel antibody structures derived from human germline sequences
10/10/2013US20130267687 Antibodies for identifying and/or isolating at least one cell population
10/10/2013US20130267686 Bispecific antibodies comprising a disulfide stabilized - fv fragment
10/10/2013US20130267685 B7-H3 and B7-H4, Novel Immunoregulatory Molecules
10/10/2013US20130267684 Method for preparing aqueous solution containing culture medium and chelating agent
10/10/2013US20130267676 Artificial antibody polypeptides
10/10/2013US20130266974 Method for diagnosing hypertension as well as cardiomyopathies
10/10/2013US20130266973 Idiotypic antibodies and uses thereof
10/10/2013US20130266972 Method of detecting protein losing enteropathy in animals
10/10/2013US20130266968 Detection of influenza virus
10/10/2013US20130266961 Diagnosis and risk stratification by means of the novel marker ct-proadm
10/10/2013US20130266930 Antibody-linked immuno-sedimentation agent and method of isolating a target from a sample using same
10/10/2013US20130266606 Polyvalent chimeric ospc vaccinogen and diagnostic antigen
10/10/2013US20130266594 Anti-notch1 antibodies
10/10/2013US20130266592 Companion animal treatments
10/10/2013US20130266587 Antibody specifically binding synovial microvasculature of arthritis patients
10/10/2013US20130266586 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266585 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266584 Methods and compositions for treating celiac disease
10/10/2013US20130266581 Anti-vegf antibodies
10/10/2013US20130266579 Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
10/10/2013US20130266577 Use of a cd28 binding substance for making a pharmaceutical composition
10/10/2013US20130266576 Therapeutic factor viii antibodies
10/10/2013US20130266574 Human antibodies to human angiopoietin-like protein 4
10/10/2013US20130266573 Specific binding proteins and uses thereof
10/10/2013US20130266571 Three-dimensional structure of complement receptor type 2 and uses thereof
10/10/2013US20130266569 Compositions and methods for diagnosing and treating cancer
10/10/2013US20130266568 Activatable bispecific antibodies
10/10/2013US20130266567 Anti-serum albumin binding single variable domains
10/10/2013US20130266566 Methods of inhibiting fibrosis using anti-pai-1 antibodies
10/10/2013US20130266565 Anti-mhc antibody anti viral cytokine fusion protein
10/10/2013US20130266564 ANTIBODIES SELECTIVE FOR CELLS PRESENTING ErbB2 AT HIGH DENSITY
10/10/2013US20130266562 Variable region sequences of il-31 monoclonal antibodies and methods of use
10/10/2013US20130266561 B-cell reduction using cd37-specific and cd20-specific binding molecules
10/10/2013US20130266560 Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
10/10/2013US20130266558 Humanized Anti-CD22 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease
10/10/2013US20130266553 Albumin Fusion Proteins
10/10/2013US20130266551 Chimeric receptors with 4-1bb stimulatory signaling domain
10/10/2013US20130266517 Humanized Antibodies That Recognize Alpha-Synuclein
10/10/2013US20130266514 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266511 Novel antigen associated with the neovasculature of tumour metastases
10/10/2013DE102012102998A1 New polymer comprising two substances that bind to amyloid-beta-oligomers, useful for treating Alzheimer's disease, Parkinson's disease, Creutzfeldt Jakob disease or diabetes
10/09/2013EP2647707A1 Cytotoxicity-inducing therapeutic agent
10/09/2013EP2647706A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
10/09/2013EP2647704A1 Polynucleotide construct capable of presenting fab in acellular translation system, and method for manufacturing and screening fab using same
10/09/2013EP2646821A2 Neoantibodies for diagnosing tissue injury
10/09/2013EP2646606A2 Surface, anchored fc-bait antibody display system
10/09/2013EP2646555A1 Methods and pharmaceutical compositions for the treatment of heart failure
10/09/2013EP2646546A1 Tomm34 peptides and vaccines including the same
10/09/2013EP2646472A1 Covalently dimerized bivalent binding agents
10/09/2013EP2646471A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
10/09/2013EP2646470A1 Low affinity blood brain barrier receptor antibodies and uses therefor
10/09/2013EP2646469A1 Chimeric rabbit/human ror1 antibodies
10/09/2013EP2646468A2 Anti-ngf compositions and use thereof
10/09/2013EP2646467A2 Improved anti-serum albumin binding single variable domains
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 1494